207 related articles for article (PubMed ID: 38054006)
1. Platelets interact with CD169
Grabowska J; Léopold V; Olesek K; Nijen Twilhaar MK; Affandi AJ; Brouwer MC; Jongerius I; Verschoor A; van Kooten C; van Kooyk Y; Storm G; van 't Veer C; den Haan JMM
Front Immunol; 2023; 14():1290272. PubMed ID: 38054006
[TBL] [Abstract][Full Text] [Related]
2. Liposomal Nanovaccine Containing α-Galactosylceramide and Ganglioside GM3 Stimulates Robust CD8
Grabowska J; Stolk DA; Nijen Twilhaar MK; Ambrosini M; Storm G; van der Vliet HJ; de Gruijl TD; van Kooyk Y; den Haan JMM
Vaccines (Basel); 2021 Jan; 9(1):. PubMed ID: 33467048
[TBL] [Abstract][Full Text] [Related]
3. Liposome induction of CD8
Grabowska J; Affandi AJ; van Dinther D; Nijen Twilhaar MK; Olesek K; Hoogterp L; Ambrosini M; Heijnen DAM; Klaase L; Hidalgo A; Asano K; Crocker PR; Storm G; van Kooyk Y; den Haan JMM
J Control Release; 2021 Mar; 331():309-320. PubMed ID: 33493613
[TBL] [Abstract][Full Text] [Related]
4. Optimization of Liposomes for Antigen Targeting to Splenic CD169
Nijen Twilhaar MK; Czentner L; Grabowska J; Affandi AJ; Lau CYJ; Olesek K; Kalay H; van Nostrum CF; van Kooyk Y; Storm G; Haan JMMD
Pharmaceutics; 2020 Nov; 12(12):. PubMed ID: 33255564
[TBL] [Abstract][Full Text] [Related]
5. Selective tumor antigen vaccine delivery to human CD169
Affandi AJ; Grabowska J; Olesek K; Lopez Venegas M; Barbaria A; Rodríguez E; Mulder PPG; Pijffers HJ; Ambrosini M; Kalay H; O'Toole T; Zwart ES; Kazemier G; Nazmi K; Bikker FJ; Stöckl J; van den Eertwegh AJM; de Gruijl TD; Storm G; van Kooyk Y; den Haan JMM
Proc Natl Acad Sci U S A; 2020 Nov; 117(44):27528-27539. PubMed ID: 33067394
[TBL] [Abstract][Full Text] [Related]
6. Functional CD169 on Macrophages Mediates Interaction with Dendritic Cells for CD8
van Dinther D; Veninga H; Iborra S; Borg EGF; Hoogterp L; Olesek K; Beijer MR; Schetters STT; Kalay H; Garcia-Vallejo JJ; Franken KL; Cham LB; Lang KS; van Kooyk Y; Sancho D; Crocker PR; den Haan JMM
Cell Rep; 2018 Feb; 22(6):1484-1495. PubMed ID: 29425504
[TBL] [Abstract][Full Text] [Related]
7. CD169
Grabowska J; Lopez-Venegas MA; Affandi AJ; den Haan JMM
Front Immunol; 2018; 9():2472. PubMed ID: 30416504
[TBL] [Abstract][Full Text] [Related]
8. Targeted delivery of herpes simplex virus glycoprotein D to CD169
Shen W; Wang C; Jiang J; He Y; Liang Q; Hu K
J Control Release; 2024 Jan; 365():208-218. PubMed ID: 37981051
[TBL] [Abstract][Full Text] [Related]
9. Targeted Delivery of Antigen to Activated CD169
Edgar LJ; Kawasaki N; Nycholat CM; Paulson JC
Cell Chem Biol; 2019 Jan; 26(1):131-136.e4. PubMed ID: 30393066
[TBL] [Abstract][Full Text] [Related]
10. Incorporation of Toll-Like Receptor Ligands and Inflammasome Stimuli in GM3 Liposomes to Induce Dendritic Cell Maturation and T Cell Responses.
Nijen Twilhaar MK; Czentner L; Bouma RG; Olesek K; Grabowska J; Wang AZ; Affandi AJ; Belt SC; Kalay H; van Nostrum CF; van Kooyk Y; Storm G; den Haan JMM
Front Immunol; 2022; 13():842241. PubMed ID: 35251040
[TBL] [Abstract][Full Text] [Related]
11. Human CLEC9A antibodies deliver NY-ESO-1 antigen to CD141
Masterman KA; Haigh OL; Tullett KM; Leal-Rojas IM; Walpole C; Pearson FE; Cebon J; Schmidt C; O'Brien L; Rosendahl N; Daraj G; Caminschi I; Gschweng EH; Hollis RP; Kohn DB; Lahoud MH; Radford KJ
J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32737142
[TBL] [Abstract][Full Text] [Related]
12. Activation of CD8⁺ T Cell Responses after Melanoma Antigen Targeting to CD169⁺ Antigen Presenting Cells in Mice and Humans.
van Dinther D; Lopez Venegas M; Veninga H; Olesek K; Hoogterp L; Revet M; Ambrosini M; Kalay H; Stöckl J; van Kooyk Y; den Haan JMM
Cancers (Basel); 2019 Feb; 11(2):. PubMed ID: 30764534
[TBL] [Abstract][Full Text] [Related]
13. CD169-positive macrophages dominate antitumor immunity by crosspresenting dead cell-associated antigens.
Asano K; Nabeyama A; Miyake Y; Qiu CH; Kurita A; Tomura M; Kanagawa O; Fujii S; Tanaka M
Immunity; 2011 Jan; 34(1):85-95. PubMed ID: 21194983
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Protein and Peptide Targeting for the Development of a CD169-Based Vaccination Strategy Against Melanoma.
van Dinther D; Veninga H; Revet M; Hoogterp L; Olesek K; Grabowska J; Borg EGF; Kalay H; van Kooyk Y; den Haan JMM
Front Immunol; 2018; 9():1997. PubMed ID: 30237798
[TBL] [Abstract][Full Text] [Related]
15. Targeted delivery of lipid antigen to macrophages via the CD169/sialoadhesin endocytic pathway induces robust invariant natural killer T cell activation.
Kawasaki N; Vela JL; Nycholat CM; Rademacher C; Khurana A; van Rooijen N; Crocker PR; Kronenberg M; Paulson JC
Proc Natl Acad Sci U S A; 2013 May; 110(19):7826-31. PubMed ID: 23610394
[TBL] [Abstract][Full Text] [Related]
16. DNGR-1-mediated cross-presentation of dead cell-associated antigens.
Henry CM; Castellanos CA; Reis e Sousa C
Semin Immunol; 2023 Mar; 66():101726. PubMed ID: 36758378
[TBL] [Abstract][Full Text] [Related]
17. Interaction of Type 1 Porcine Reproductive and Respiratory Syndrome Virus With
Li Y; Mateu E
Front Immunol; 2021; 12():674185. PubMed ID: 34177915
[TBL] [Abstract][Full Text] [Related]
18. T cell priming against vesicular stomatitis virus analyzed in situ: red pulp macrophages, but neither marginal metallophilic nor marginal zone macrophages, are required for priming CD4+ and CD8+ T cells.
Ciavarra RP; Buhrer K; Van Rooijen N; Tedeschi B
J Immunol; 1997 Feb; 158(4):1749-55. PubMed ID: 9029112
[TBL] [Abstract][Full Text] [Related]
19. Cross-presentation of dead-cell-associated antigens by DNGR-1
Balam S; Kesselring R; Eggenhofer E; Blaimer S; Evert K; Evert M; Schlitt HJ; Geissler EK; van Blijswijk J; Lee S; Reis e Sousa C; Brunner SM; Fichtner-Feigl S
Eur J Immunol; 2020 Dec; 50(12):2041-2054. PubMed ID: 32640051
[TBL] [Abstract][Full Text] [Related]
20. A Protective Role for the Lectin CD169/Siglec-1 against a Pathogenic Murine Retrovirus.
Uchil PD; Pi R; Haugh KA; Ladinsky MS; Ventura JD; Barrett BS; Santiago ML; Bjorkman PJ; Kassiotis G; Sewald X; Mothes W
Cell Host Microbe; 2019 Jan; 25(1):87-100.e10. PubMed ID: 30595553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]